D. Western Therapeutics Institute Inc
D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on developing drugs to serve patients worldwide. The company offers GLANATEC, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM staining and peeling. It is also developing H-1337, a multikinase inhibitor that has completed Phase I/IIa clinical trials for the treatment of glaucoma/ocular hypertension; K-134, an antiplatelet agent, which has completed Phase IIb trials to treat arteriosclerosis obliterans; DW-1001, an ophthalmic treatment agent in nonclinical studies; and DW-5LBT, a lidocaine patch for neuropathic pain after shingles. The company was founded in 1999 and is headquartered in Nagoya, Japan. Show More...
-
Website https://www.dwti.co.jp
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.55 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share JPY -24.18 -20.46 -14.49 -10.49 -8.47 -12.99 -10.46 -59.89 -28.51 5.07 -2.4 Dividends JPY Payout Ratio % * Shares Mil 17.0 17.0 18.0 21.0 23.0 23.0 24.0 26.0 26.0 26.0 26.0 Book Value Per Share * EUR 0.4 0.22 0.7 0.64 0.64 0.92 0.63 0.43 0.43 0.43 Free Cash Flow Per Share * EUR -0.2 -0.16 -0.06 -0.08 -0.09 -0.1 -0.17 -0.19 -0.04 Return on Assets % -34.82 -42.82 -45.21 -16.1 -8.7 -13.87 -10.03 -54.0 -30.25 6.57 -3.18 Financial Leverage (Average) 1.02 1.04 1.03 1.01 1.01 1.12 1.06 1.44 1.64 1.42 1.39 Return on Equity % -35.57 -44.16 -46.99 -16.33 -8.79 -14.7 -10.89 -65.98 -45.94 10.04 -4.56 Return on Invested Capital % -35.66 -44.24 -47.06 -16.37 -8.89 -14.83 -10.98 -52.54 -32.52 7.44 -3.13 Interest Coverage -296.27 -125.13 19.65 -14.6 Current Ratio 40.89 24.68 29.75 100.83 108.32 74.3 78.13 16.1 6.58 9.07 10.08 Quick Ratio 40.61 24.38 29.14 100.31 106.2 71.65 75.6 14.04 6.17 8.69 9.62 Debt/Equity 0.3 0.38 0.26 0.24